CMV-specific T cell therapy

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 1, 2008, Pages 71-75

  Einsele, Hermann ^a   Kapp, Markus ^a   Grigoleit, Götz Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adoptive immunotherapy; CMV; T cell

Indexed keywords

ANTIVIRUS AGENT;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL THERAPY; CELLULAR IMMUNITY; CYTOMEGALOVIRUS INFECTION; HUMAN; INFECTION PREVENTION; INFUSION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANTIGENS, VIRAL; CYTOMEGALOVIRUS INFECTIONS; HUMANS; LYMPHOCYTE TRANSFUSION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 5;

EID: 36549077640     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.07.002     Document Type: Article

References (26)

1. Boeckh M., Bowden R.A., Gooley T., et al. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 93 (1999) 1781-1782
2. Einsele H., Ehninger G., Hebart H., et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86 (1995) 2815-2820
3. Ljungman P., Engelhard D., Link H., et al. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin. Infect. Dis. 14 (1992) 831-835
4. Einsele H., Hebart H., Kauffmann-Schneider C., et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. 25 (2000) 757-763
5. Krause H., Hebart H., Jahn G., et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant. 19 (1997) 1111-1116
6. Zaia J.A., Gallez-Hawkins G.M., Tegtmeier B.R., et al. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J. Infect. Dis. 176 (1997) 782-785
7. Reusser P., Riddell S.R., Meyers J.D., and Greenberg P.D. Cytotoxic T lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78 (1991) 1373-1380
8. Ljungman P., Lonnqvist B., Wahren B., et al. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients-a one-year follow-up. Transplantation 40 (1985) 515-520
9. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995) 1038-1044
10. Kern F., Bunde T., Faulhaber N., et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185 (2002) 1709-1716
11. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99 (1997) 1739-1750
12. Riddell S.R., Watanabe K.S., Goodrich J.M., et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones. Science 257 (1992) 238-241
13. Einsele H., Roosnek E., Rufer N., et al. Infusion of cytomegalovirus (CMV)-specific T-cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99 (2002) 3916-3922
14. Szmania S., Galloway A., Bruorton M., et al. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 98 (2001) 505-512
15. Koehne G., Gallardo H.F., Sadelain M., and O'Reilly R.J. Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood 96 (2000) 109-117
16. Kondo E., Topp M.S., Kiem H.P., et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J. Immunol. 169 (2002) 2164-2171
17. Kleihauer A., Grigoleit U., Hebart H., et al. Ex vivo generation of human cytomegalovirus-specific cytotoxic T-cells by peptide-pulsed dendritic cells. Br. J. Haematol. 113 (2001) 231-239
18. *0201-restricted peptide. Br. J. Haematol. 113 (2001) 479-482
19. Peggs K., Verfuerth S., and Mackinnon S. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 97 (2001) 994-1000
20. Koehne G., Smith K.M., Ferguson T.L., et al. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood 99 (2002) 1730-1740
21. Altman J.D., Moss P.A., Goulder P.J., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
22. Keenan R.D., Ainsworth J., Khan N., et al. Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers. Br. J. Haematol. 115 (2001) 428-434
23. Cobbold M., Khan N., Pourgheysari B., et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202 (2005) 379-386
24. Knabel M., Franz T.J., Schiemann M., et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8 (2002) 631-637
25. Tan R., Xu X., Ogg G.S., et al. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood 93 (1999) 1506-1510
26. + T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103 (2004) 3565-3572